Spots Global Cancer Trial Database for dendritic cell
Every month we try and update this database with for dendritic cell cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| DC Vaccine for Patients With Ductal Carcinoma In Situ | NCT02061332 | Breast Cancer DCIS | HER-2 Pulsed De... | 18 Years - | Abramson Cancer Center at Penn Medicine | |
| Local Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic Melanoma | NCT01216436 | Metastatic Mela... | Vaccination wit... | 18 Years - | Duke University | |
| RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients. | NCT04963413 | Glioblastoma | Autologous DCs ... | 18 Years - 90 Years | University of Florida | |
| Local Modulation of Immune Receptors to Enhance the Response to Dendritic Cell Vaccination in Metastatic Melanoma | NCT01216436 | Metastatic Mela... | Vaccination wit... | 18 Years - | Duke University | |
| HER-2 Pulsed DC Vaccine to Prevent Recurrence of Invasive Breast Cancer Post Neoadjuvant Chemotherapy | NCT02061423 | Breast Cancer | HER-2 pulsed De... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Safety Study of BPX-201 Dendritic Cell Vaccine Plus AP1903 in Metastatic Castrate Resistent Prostate Cancer | NCT01823978 | Castrate Resist... | BPX-201 vaccine... | 18 Years - | Bellicum Pharmaceuticals | |
| Dendritic Cell Vaccine for Head and Neck Cancer | NCT00492947 | Squamous Cell C... | dendritic cell ... | 18 Years - | University of Maryland, Baltimore | |
| Dendritic Cell Cancer Vaccine for High-grade Glioma | NCT01213407 | Glioblastoma Mu... | Trivax, Temozol... Temozolomide, S... | 3 Years - 70 Years | Activartis Biotech | |
| Survivin Vaccine : Multiple Myeloma Autologous Hematopoietic Cell Transplant (HCT) | NCT02851056 | Multiple Myelom... | Survivin Vaccin... Autologous Hema... Prevnar 13 Granulocyte-col... | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Safety Study of BPX-201 Dendritic Cell Vaccine Plus AP1903 in Metastatic Castrate Resistent Prostate Cancer | NCT01823978 | Castrate Resist... | BPX-201 vaccine... | 18 Years - | Bellicum Pharmaceuticals | |
| Transfected Dendritic Cell Based Therapy for Patients With Breast Cancer or Malignant Melanoma | NCT00978913 | Breast Cancer Malignant Melan... | DC vaccine | 18 Years - | Herlev Hospital | |
| Phase I Clinical Trial of Cryoimmunotherapy Against Prostate Cancer | NCT02423928 | Prostate Cancer | Dendritic cell ... Cyclophosphamid... ipilimumab | 18 Years - | Alden Cancer Therapy II | |
| MIDRIXNEO-LUNG Dendritic Cell Vaccine in Patients With Non-small Cell Lung Cancer | NCT04078269 | Non-small Cell ... | Dendritic cell ... Antigen-specifi... Control DTH | 18 Years - | University Hospital, Ghent | |
| Phase I Study of Combined Immune Cell Therapy in Patients With Stage 4 Colorectal Cancer With Metastatic Lesion Who Failed Prior Standard of Care | NCT06296056 | Colorectal Canc... Metastatic Colo... | Combi | 19 Years - | Seoul Hospital | |
| Dendritic Cell Vaccination With Standard Postoperative Chemotherapy for the Treatment of Adult Ovarian Cancer | NCT05270720 | Recurrent Ovari... | dendritic cell | 18 Years - 75 Years | West China Second University Hospital | |
| MIDRIX4-LUNG Dendritic Cell Vaccine in Patients With Metastatic Non-small Cell Lung Cancer | NCT04082182 | Non-small Cell ... | Dendritic cell ... Antigen-specifi... Control DTH | 18 Years - | University Hospital, Ghent | |
| RENEW: Feasibility of CMV RNA-Pulsed Dendritic Cells Vaccines for the Treatment of Newly Diagnosed Glioblastoma Patients. | NCT04963413 | Glioblastoma | Autologous DCs ... | 18 Years - 90 Years | University of Florida | |
| Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients | NCT00722098 | Malignant Melan... | DC Vaccine & Cy... DC Vaccine & Pl... | 21 Years - 75 Years | Baylor Research Institute | |
| A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies | NCT03329950 | Melanoma Non-small Cell ... Breast Cancer Gastric Cancer Renal Cell Carc... Ovarian Cancer Cholangiocarcin... Bladder Urothel... Pancreatic Aden... Colorectal Canc... Esophageal Canc... Hepatic Cancer Head and Neck C... Primary Periton... Fallopian Tube ... Other Solid Tum... Diffuse Large B... Mantle Cell Lym... Indolent B-cell... Non-Hodgkin Lym... Follicular Lymp... Lymphoplasmacyt... Waldenstrom's D... Marginal Zone L... Mucosa Associat... Small Lymphocyt... | CDX-1140 CDX-301 pembrolizumab Chemotherapy | 18 Years - | Celldex Therapeutics | |
| Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment | NCT00154713 | Colorectal Canc... | CEA pulsed dend... | 20 Years - 75 Years | National Taiwan University Hospital | |
| Hypomemylating Agents Combination With eDC Therapy for Elderly Patients With Myelodysplastic Syndrome | NCT04999943 | Myelodysplastic... Dendritic Cell Hypomethylating... Immunotherapy | DC vaccine | 60 Years - | Affiliated Hospital to Academy of Military Medical Sciences | |
| Dendritic Cell Vaccine for Children and Adults With Sarcoma | NCT01803152 | Sarcoma Soft Tissue Sar... Bone Sarcoma | Dendritic Cells... Lysate of Tumor Gemcitabine Imiquimod Leukapheresis | 1 Year - 100 Years | University of Miami | |
| Efficacy and Safety of Endoscopic Ultrasound Guided Fine-needle Injection of Dendritic Cells Vaccination Into Unresectable Pancreatic Cancer | NCT01897636 | Pancreatic Canc... | EUS-guided fine... | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells | NCT00672542 | Metastatic Mela... Absence of CNS ... | Proteasome siRN... | 18 Years - | Duke University | |
| A Safety and Feasibility Study of AGS-003-LNG for the Treatment of Stage 3 Non Small Cell Lung Cancer | NCT02662634 | Non-small Cell ... | AGS-003-LNG Carboplatin Abraxane Alimta Cisplatin Taxol Radiation Thera... | 19 Years - | GU Research Network, LLC | |
| IL15 Dendritic Cell Vaccine for Patients With Resected Stage III (A, B or C) or Stage IV Melanoma | NCT01189383 | Malignant Melan... Malignant Melan... | IL15-DC Vaccine | 21 Years - 75 Years | Baylor Research Institute | |
| Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma | NCT02638857 | Recurrence Hepa... Advanced Hepato... | TACE Dendritic Cell lipiodol Mitomycin (MMC) Epirubicin(EADM... Precision Multi... | 18 Years - 65 Years | Second Military Medical University | |
| Dendritic Cell Based Therapy for Breast Cancer Patients | NCT00935558 | Breast Cancer | DC vaccine aromatase inhib... | 18 Years - | Herlev Hospital | |
| Phase I Clinical Trial of Cryoimmunotherapy Against Prostate Cancer | NCT02423928 | Prostate Cancer | Dendritic cell ... Cyclophosphamid... ipilimumab | 18 Years - | Alden Cancer Therapy II | |
| A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies | NCT03329950 | Melanoma Non-small Cell ... Breast Cancer Gastric Cancer Renal Cell Carc... Ovarian Cancer Cholangiocarcin... Bladder Urothel... Pancreatic Aden... Colorectal Canc... Esophageal Canc... Hepatic Cancer Head and Neck C... Primary Periton... Fallopian Tube ... Other Solid Tum... Diffuse Large B... Mantle Cell Lym... Indolent B-cell... Non-Hodgkin Lym... Follicular Lymp... Lymphoplasmacyt... Waldenstrom's D... Marginal Zone L... Mucosa Associat... Small Lymphocyt... | CDX-1140 CDX-301 pembrolizumab Chemotherapy | 18 Years - | Celldex Therapeutics | |
| Efficacy and Safety of Endoscopic Ultrasound Guided Fine-needle Injection of Dendritic Cells Vaccination Into Unresectable Pancreatic Cancer | NCT01897636 | Pancreatic Canc... | EUS-guided fine... | 18 Years - | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | |
| Dendritic Cell Based Therapy of Renal Cell Carcinoma | NCT00197860 | Advanced Renal ... | tumor antigen l... | 18 Years - | Herlev Hospital | |
| Dendritic Cells in Lung Cancer | NCT00442754 | Non Small Cell ... | Allogeneic Tumo... | 18 Years - | Herlev Hospital | |
| A Study of Vaccination With Poly-ICLC and Dendritic Cells in Patients With Pancreatic Adenocarcinoma | NCT01677962 | Pancreatic Aden... | Poly-ICLC dendritic cell | 18 Years - | Medical University of South Carolina | |
| A Study Combining Personalized Neoantigen-based Dendritic Cell Vaccine With Microwave Ablation for the Treatment of Hepatocellular Carcinoma | NCT03674073 | Hepatocellular ... Liver Cancer, A... | Neoantigen Vacc... Microwave Ablat... | 18 Years - | Chinese PLA General Hospital | |
| Immunotherapy for Colorectal Cancers Using CEA-Pulsed Dendritic Cells and Subsequent IL-2 Treatment | NCT00154713 | Colorectal Canc... | CEA pulsed dend... | 20 Years - 75 Years | National Taiwan University Hospital | |
| Trial of Antigen Pulsed Dendritic Cells (APDC) in Metastatic Colorectal Cancer | NCT02503150 | Metastatic Colo... | APDC + Chemothe... Chemotherapy | 18 Years - 75 Years | Second Military Medical University | |
| A Study of Vaccination With Poly-ICLC and Dendritic Cells in Patients With Pancreatic Adenocarcinoma | NCT01677962 | Pancreatic Aden... | Poly-ICLC dendritic cell | 18 Years - | Medical University of South Carolina | |
| Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas | NCT03334305 | Malignant Gliom... High Grade Glio... | TTRNA-DC vaccin... Dose-intensifie... Autologous Hema... TTRNA-xALT Td vaccine | 3 Years - 21 Years | University of Florida | |
| Immunotherapy of Melanoma With Tumor Antigen RNA and Small Inhibitory RNA Transfected Autologous Dendritic Cells | NCT00672542 | Metastatic Mela... Absence of CNS ... | Proteasome siRN... | 18 Years - | Duke University | |
| Immunotherapy Using Precision T Cells Specific to Multiple Common Tumor-Associated Antigen Combined With Transcatheter Arterial Chemoembolization for the Treatment of Advanced Hepatocellular Carcinoma | NCT02638857 | Recurrence Hepa... Advanced Hepato... | TACE Dendritic Cell lipiodol Mitomycin (MMC) Epirubicin(EADM... Precision Multi... | 18 Years - 65 Years | Second Military Medical University | |
| Hypomemylating Agents Combination With eDC Therapy for Elderly Patients With Myelodysplastic Syndrome | NCT04999943 | Myelodysplastic... Dendritic Cell Hypomethylating... Immunotherapy | DC vaccine | 60 Years - | Affiliated Hospital to Academy of Military Medical Sciences | |
| A Study to Evaluate the Safety and Effectiveness of ILIxadencel Administered Into Tumors in Combination With Checkpoint Inhibitor (CPI) in Patients With ADvanced Cancer | NCT03735290 | Carcinoma, Squa... Gastric Adenoca... Gastroesophagea... Non-small Cell ... | ilixadencel Pembrolizumab | 18 Years - | Mendus | |
| Comparison Study of Dendritic Cell Vaccine With and Without Cyclophosphamide to Treat Stage IV Melanoma Patients | NCT00722098 | Malignant Melan... | DC Vaccine & Cy... DC Vaccine & Pl... | 21 Years - 75 Years | Baylor Research Institute | |
| Dendritic Cell Vaccine for Head and Neck Cancer | NCT00492947 | Squamous Cell C... | dendritic cell ... | 18 Years - | University of Maryland, Baltimore |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
